Login

David Gandler, CEO of Fubo TV, discusses the impact of the merger between competitors DISH and DirecTV on 'Closing Bell'. 00:10:00

Share On Facebook Share On Twitter

David Gandler is Co-founder and CEO of FuboTV Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
John Koudounis on Sustainability and Investment at the 28th Annual Economist Government Roundtable
00:10:00
leading investments in transformative companies building in future tech|Rebecca Lynn,General Partner,Canvas Ventures
00:10:00
Presentation on Namibian Critical Metals Portfolio
00:10:00
Everything about the new bottle of “Tissir Gaz” | Hadj Ali Wakrim, CEO, Afriquia Gaz SAGAZ:CAS
00:00:00
Eden Research list in US to 'access world's largest capital markets' and seize opportunities - Sean Smith, CEO, Eden Research
00:10:00
Updates on OvaSuite®, OvaWatchSM, and EndoCheckTM Discussed in Fireside Chat with CEO| Nicole Sandford, CEO, Aspira Women's Health Inc.
00:10:00
Highcroft Mining's Unprecedented Silver Discovery and Expansion Plans for 2024
00:10:00
How Implementing EOS Transformed Our Business Operations
00:10:00
its not just enough to put them up on the wall and distribute those laminated cards that people|Jeff Cantalupo,Founder & Managing Partner,Listen Ventures
00:10:00
State Street Leads Clean Economy Transition: CEO Ron O'Hanley Shares Firm's ESG Priorities| Ron O’Hanley,CEO, State Street
00:00:00
Dr. Pitor Kopinski - Residency at Mayo Clinic
00:10:00
Gavin Rochussen, Chief Executive Officer, and Samir Ayub, Group Finance Director at Polar Capital Holdings - Presenting the Interim Financial Results and Strategic Vision for Sustainable Growth

© 2017 - Neuhu+